413 related articles for article (PubMed ID: 30694445)
1. Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005-2016.
Kim D; Kim W; Adejumo AC; Cholankeril G; Tighe SP; Wong RJ; Gonzalez SA; Harrison SA; Younossi ZM; Ahmed A
Hepatol Int; 2019 Mar; 13(2):205-213. PubMed ID: 30694445
[TBL] [Abstract][Full Text] [Related]
2. Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011-2016.
Le MH; Yeo YH; Cheung R; Wong VW; Nguyen MH
J Intern Med; 2020 Jun; 287(6):711-722. PubMed ID: 32128904
[TBL] [Abstract][Full Text] [Related]
3. Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018.
Wang T; Xi Y; Raji A; Crutchlow M; Fernandes G; Engel SS; Zhang X
Ann Hepatol; 2024; 29(1):101154. PubMed ID: 37742743
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and outcomes of non-alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States.
Golabi P; Paik J; Hwang JP; Wang S; Lee HM; Younossi ZM
Liver Int; 2019 Apr; 39(4):748-757. PubMed ID: 30597715
[TBL] [Abstract][Full Text] [Related]
6. Depression is associated with non-alcoholic fatty liver disease among adults in the United States.
Kim D; Yoo ER; Li AA; Tighe SP; Cholankeril G; Harrison SA; Ahmed A
Aliment Pharmacol Ther; 2019 Sep; 50(5):590-598. PubMed ID: 31328300
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of High and Moderate Risk Nonalcoholic Fatty Liver Disease Among Adults in the United States, 1999-2016.
Golabi P; Paik JM; Harring M; Younossi E; Kabbara K; Younossi ZM
Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2838-2847.e7. PubMed ID: 34929391
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States.
Le MH; Devaki P; Ha NB; Jun DW; Te HS; Cheung RC; Nguyen MH
PLoS One; 2017; 12(3):e0173499. PubMed ID: 28346543
[TBL] [Abstract][Full Text] [Related]
9. Associations of different serum folate forms with indices of nonalcoholic fatty liver disease and advanced fibrosis.
Yang S; Ye Z; Liu M; Zhang Y; Wu Q; Zhou C; Zhang Z; He P; Zhang Y; Li H; Liu C; Qin X
Obes Res Clin Pract; 2023; 17(1):58-65. PubMed ID: 36746711
[TBL] [Abstract][Full Text] [Related]
10. The Association between Non-Alcoholic Fatty Liver Disease (NAFLD) and Advanced Fibrosis with Serological Vitamin B12 Markers: Results from the NHANES 1999-2004.
Li L; Huang Q; Yang L; Zhang R; Gao L; Han X; Ji L; Zou X
Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334881
[TBL] [Abstract][Full Text] [Related]
11. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States.
Kim D; Kim WR; Kim HJ; Therneau TM
Hepatology; 2013 Apr; 57(4):1357-65. PubMed ID: 23175136
[TBL] [Abstract][Full Text] [Related]
12. Race/ethnic and sex disparities in the non-alcoholic fatty liver disease-abdominal aortic calcification association: The Multi-Ethnic Study of Atherosclerosis.
Remigio-Baker RA; Allison MA; Forbang NI; Loomba R; Anderson CAM; Budoff M; Schwimmer JB; Blumenthal RS; Ouyang P; Criqui MH
Atherosclerosis; 2017 Mar; 258():89-96. PubMed ID: 28235711
[TBL] [Abstract][Full Text] [Related]
13. Association of lifestyle behaviors with non-alcoholic fatty liver disease and advanced fibrosis detected by transient elastography among Hispanic/Latinos adults in the U.S.
Heredia NI; Zhang X; Balakrishnan M; Hwang JP; Thrift AP
Ethn Health; 2023 Feb; 28(2):299-312. PubMed ID: 35067116
[TBL] [Abstract][Full Text] [Related]
14. The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.
Jinjuvadia R; Antaki F; Lohia P; Liangpunsakul S
J Clin Gastroenterol; 2017 Feb; 51(2):160-166. PubMed ID: 27580477
[TBL] [Abstract][Full Text] [Related]
15. Leucocyte telomere shortening is associated with nonalcoholic fatty liver disease-related advanced fibrosis.
Kim D; Li AA; Ahmed A
Liver Int; 2018 Oct; 38(10):1839-1848. PubMed ID: 29797393
[TBL] [Abstract][Full Text] [Related]
16. Serum 25-hydroxyvitamin-D and nonalcoholic fatty liver disease: Does race/ethnicity matter? Findings from the MESA cohort.
El Khoudary SR; Samargandy S; Zeb I; Foster T; de Boer IH; Li D; Budoff MJ
Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):114-122. PubMed ID: 31761548
[TBL] [Abstract][Full Text] [Related]
17. Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA.
Wijarnpreecha K; Kim D; Raymond P; Scribani M; Ahmed A
Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1121-1128. PubMed ID: 30888971
[TBL] [Abstract][Full Text] [Related]
18. The Prevalence and Pathobiology of Nonalcoholic Fatty Liver Disease in Patients of Different Races or Ethnicities.
Kalia HS; Gaglio PJ
Clin Liver Dis; 2016 May; 20(2):215-24. PubMed ID: 27063265
[TBL] [Abstract][Full Text] [Related]
19. Association of weight-adjusted-waist index with non-alcoholic fatty liver disease and liver fibrosis: a cross-sectional study based on NHANES.
Hu Q; Han K; Shen J; Sun W; Gao L; Gao Y
Eur J Med Res; 2023 Aug; 28(1):263. PubMed ID: 37537679
[TBL] [Abstract][Full Text] [Related]
20. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
